PURPOSE: To describe the characteristics and outcomes of patients with cytomegalovirus
(CMV) retinitis in the absence of human immunodeficiency virus (HIV) infection. DESIGN …

PURPOSE: To assess the impact of highly active antiretroviral therapy on the epidemiology
of cytomegalovirus retinitis in patients infected with the human immunodeficiency virus (HIV) …

Purpose To evaluate clinical features and long-term visual outcome of cytomegalovirus
(CMV) retinitis in patients without human immunodeficiency virus (HIV) infection, and to …

Background: Patient survival with the acquired immune deficiency syndrome (AIDS) and
cytomegalovirus (CMV) retinitis is increasing because of earlier diagnosis and improved …

PURPOSE: To estimate the incidence of cytomegalovirus (CMV) retinitis in the era of highly
active antiretroviral therapy (HAART) and to characterize the factors associated with …

Objective To characterize the effect of cytomegalovirus (CMV) retinitis and its treatment on
visual acuity in patients with the acquired immunodeficiency syndrome. Methods We …

PURPOSE: To describe host characteristics (use of highly active antiretroviral therapy
[HAART]; CD4+ T-lymphocyte count; HIV ribonucleic acid [RNA] blood level) of people who …

Objective To identify ocular and systemic factors that predict advancement of
cytomegalovirus (CMV) retinitis during treatment. Methods Patients with acquired …

PURPOSE:: To update information on cytomegalovirus (CMV) retinitis in patients with
acquired immunodeficiency syndrome (AIDS) and to integrate information on its …

Purpose To describe the long-term outcomes of patients with cytomegalovirus (CMV) retinitis
and AIDS in the modern era of combination antiretroviral therapy. Design Prospective …